242 related articles for article (PubMed ID: 23283457)
41. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
42. Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.
Faust L; Klowak M; MacRae C; Kopalakrishnan S; Showler AJ; Boggild AK
J Cutan Med Surg; 2021; 25(1):45-52. PubMed ID: 32869655
[TBL] [Abstract][Full Text] [Related]
43. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
[TBL] [Abstract][Full Text] [Related]
44. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
Thomas A; Balakrishnan A; Nagarajan M; Prabhakar R; Tripathy SP; Christian M; Somasundaram PR
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
[TBL] [Abstract][Full Text] [Related]
45. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
46. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
47. Hepatic and haematological adverse reactions associated with the use of multidrug therapy in leprosy--a five year retrospective study.
Kaluarachchi SI; Fernandopulle BM; Gunawardane BP
Indian J Lepr; 2001; 73(2):121-9. PubMed ID: 11579648
[TBL] [Abstract][Full Text] [Related]
48. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
[TBL] [Abstract][Full Text] [Related]
49. Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR).
Ferreira IP; Buhrer-Sékula S; De Oliveira MR; Gonçalves Hde S; Pontes MA; Penna ML; Cruz R; Penna GO
Lepr Rev; 2014 Dec; 85(4):267-74. PubMed ID: 25675651
[TBL] [Abstract][Full Text] [Related]
50. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
[TBL] [Abstract][Full Text] [Related]
51. Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
Rao PS; Ramachandran A; Sekar B; Ravi S; Subramanian M
Lepr Rev; 1994 Sep; 65(3):181-9. PubMed ID: 8942149
[TBL] [Abstract][Full Text] [Related]
52. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
53. Dapsone-induced photosensitivity: a rare clinical presentation.
Kar BR
Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):270-1. PubMed ID: 18811870
[TBL] [Abstract][Full Text] [Related]
54. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
[TBL] [Abstract][Full Text] [Related]
55. Dapsone syndrome in a Filipino man.
Hortaleza AR; Salta-Ramos NG; Barcelona-Tan J; Abad-Venida L
Lepr Rev; 1995 Dec; 66(4):307-13. PubMed ID: 8637384
[TBL] [Abstract][Full Text] [Related]
56. A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
Thomas A; Nagarajan M; Chandrasekaran V; Hari L; Somasundaram PR; Prabhakar R; Kumar A; Bhatia VN; Roy RG
Indian J Lepr; 1988 Oct; 60(4):499-505. PubMed ID: 3075630
[TBL] [Abstract][Full Text] [Related]
57. Multiple livid-erythematous macules and plaques with slight scaling in a young man.
Müller A; Wolfsperger F; Kofler L; Yazdi AS
J Dtsch Dermatol Ges; 2018 Oct; 16(10):1282-1285. PubMed ID: 30248227
[No Abstract] [Full Text] [Related]
58. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
Balakrishnan S; Karthikeyan S; Ramu G
Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
[TBL] [Abstract][Full Text] [Related]
59. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
60. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
Singh H; Nel B; Dey V; Tiwari P; Dulhani N
Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
